Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT02781857
Mass Spectral Fingerprinting in Lung Cancer
Sponsor: University of Zurich
View on ClinicalTrials.gov
Summary
To answer the question whether a disease specific profile of breath in patients with lung cancer can be detected by an untargeted metabolomic study using exhaled breath analysis by mass spectrometry.
Official title: Exhaled Breath Analysis by Secondary Electrospray Ionization - Mass Spectrometry (SESI-MS) in Patients With Lung Cancer
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
OBSERVATIONAL
Enrollment
393
Start Date
2016-05
Completion Date
2025-03-31
Last Updated
2025-03-20
Healthy Volunteers
No
Conditions
Interventions
OTHER
No intervention
Locations (1)
University Hospital Zurich, Division of Pneumology
Zurich, Canton of Zurich, Switzerland